Mycophenolate Mofetil: A New Immunosuppressive ApproachSuccessful Treatment in a Case of Myasthenia gravis Associated with Incomplete Lupus erythematosus Syndrome and Hepatitis C Virus Infection

Publisher： Karger

E-ISSN： 1421-9913|46|1|53-54

ISSN： 0014-3022

Source： European Neurology, Vol.46, Iss.1, 2001-07, pp. : 53-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental—two case reports and review of the literature

By Bhinder Sumeet   Majithia Vikas   Harisdangkul Valee  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 555-556

Springer Publishing Company

Access to resources Recommend Favorite

Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 79-82

Karger

Access to resources Recommend Favorite

Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy

By Watanabe Ryu   Ishii Tomonori   Nakamura Kyohei   Shirai Tsuyoshi   Tajima Yumi   Fujii Hiroshi   Harigae Hideo  

Modern Rheumatology, Vol. 23, Iss. 6, 2013-11 ,pp. : 1094-1100

Springer Publishing Company

Access to resources Recommend Favorite

The Course of Myasthenia Gravis with Systemic Lupus Erythematosus

By  

European Neurology, Vol. 72, Iss. 5-6, 2014-10 ,pp. : 326-329

Karger

Access to resources Recommend Favorite

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu   Weng Chia-Tse   Liu Ming-Fei  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite